Table 3.
FIV (ml) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) |
---|---|---|---|---|
mRS 0–2 | ||||
⩽5 ml | 0.4 (0.29–0.51) | 0.94 (0.82–0.99) | 0.92 (0.78–0.98) | 0.47 (0.36–0.57) |
⩽15 ml a | 0.75 (0.64–0.84) | 0.79 (0.64–0.89) | 0.86 (0.76–0.93) | 0.64 (0.5–0.76) |
⩽40 ml | 0.89 (0.8–0.95) | 0.43 (0.28–0.58) | 0.73 (0.64–0.82) | 0.69 (0.49–0.85) |
mRS 0–1 | ||||
⩽5 ml | 0.43 (0.31–0.55) | 0.9 (0.79–0.96) | 0.83 (0.67–0.94) | 0.57 (0.47–0.68) |
⩽15 ml a | 0.77 (0.66–0.86) | 0.7 (0.57–0.81) | 0.75 (0.63–0.84) | 0.72 (0.59–0.83) |
⩽40 ml | 0.9 (0.8–0.96) | 0.37 (0.25–0.5) | 0.62 (0.52–0.72) | 0.76 (0.56–0.9) |
PPV: Positive predictive value; NPV: Negative predictive value; FIV (ml): follow up infarct volume; CI: Confidence Interval.
Youden index cut-off point.